Not all people with CLL demand therapy. Despite all modern improvements, the iwCLL however suggests watchful observation for individuals with asymptomatic sickness.86 This advice is predicated on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both tr